Urology · Manhattan, KS
NPI
1902909138
Since 2006
Specialty
Urology
Code 208800000X
Group practices
5
Medicare group memberships
Hospitals
5
Hospital affiliations
1133 College Ave
Manhattan, KS, 66502
Phone (785) 537-8710
Groups this clinician bills Medicare through
Medicare paid, 2024
$349K
3,839 services
Medicare patients, 2024
1,569
Average age 75
Drug cost, 2024
$736K
2,313 prescriptions
Company payments, 2025
$651
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Apostolos Evangelidis was code 99214 (office e&m - established), 741 times for 533 patients. In total Apostolos Evangelidis billed 3,839 services in 94 codes, and Medicare paid $349K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-09-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 741 | 533 | $86.39 | $64K |
| 99213 Office E&M - Established | Office | 526 | 475 | $58.78 | $31K |
| 52000 Cystourethroscopy | Facility | 331 | 291 | $55.57 | $18K |
| J9217 Leuprolide acetate (for depot suspension), 7.5 mg | Office | 224 | 29 | $138.16 | $31K |
| 99213 Office E&M - Established | Facility | 209 | 188 | $43.88 | $9,172 |
| 99214 Office E&M - Established | Facility | 169 | 131 | $65.27 | $11K |
| 99204 Office E&M - New | Office | 163 | 163 | $102.64 | $17K |
| 81001 Clinical Chemistry | Office | 117 | 110 | $3.06 | $359 |
| 81003 Clinical Chemistry | Office | 96 | 93 | $2.20 | $211 |
| 51741 Test - Miscellaneous | Office | 59 | 57 | $5.69 | $336 |
| 99204 Office E&M - New | Facility | 59 | 59 | $93.25 | $5,502 |
| 99215 Office E&M - Established | Office | 56 | 49 | $127.17 | $7,122 |
| 99211 Office E&M - Established | Office | 54 | 30 | $17.17 | $927 |
| 76872 Ultrasound - Nonspecific | Facility | 54 | 54 | $23.76 | $1,283 |
| 55700 Other Organ Systems | Facility | 53 | 53 | $92.65 | $4,910 |
By year: 2022 $265K for 3,496 services; 2023 $304K for 3,742 services; 2024 $349K for 3,839 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81001 Clinical Chemistry | 117 | 110 | $3.06 | $359 |
| 81003 Clinical Chemistry | 96 | 93 | $2.20 | $211 |
Medicare prescription drug claims, 2024
In 2024, the drug Apostolos Evangelidis prescribed most often to Medicare patients was Tamsulosin Hcl, with 761 prescriptions and refills. In total Apostolos Evangelidis wrote 2,313 Medicare prescriptions that cost $736K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tamsulosin Hcl Generic | 761 | 1,743 | 223 | $7,928 |
| Myrbetriq Mirabegron | 196 | 264 | 39 | $115K |
| Solifenacin Succinate Generic | 139 | 279 | 50 | $5,488 |
| Water Water For Irrigation,sterile | 92 | 92 | Under 11 | $4,438 |
| Finasteride Generic | 72 | 160 | 21 | $939 |
| Gemtesa Vibegron | 62 | 85 | 15 | $39K |
| Methenamine Hippurate Generic | 57 | 63 | Under 11 | $1,879 |
| Hydrochlorothiazide Generic | 56 | 120 | 15 | $183 |
| Potassium Citrate Er Potassium Citrate | 55 | 75 | 11 | $7,402 |
| Testosterone Cypionate Generic | 53 | 56 | Under 11 | $1,709 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 47 | 47 | 42 | $150 |
| Ciprofloxacin Hcl Generic | 42 | 46 | 35 | $138 |
| Allopurinol Generic | 39 | 91 | Under 11 | $371 |
| Desmopressin Acetate Generic | 36 | 38 | Under 11 | $1,576 |
| Nitrofurantoin Nitrofurantoin Macrocrystal | 36 | 48 | Under 11 | $730 |
Brand drugs: - claims; generic drugs: 1,885 claims; opioid claims: 47.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Apostolos Evangelidis $651 ($651 in general payments such as food, travel and fees) from 14 companies. The largest payer was Janssen Biotech, Inc. with $143.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 4 | $143 |
| HealthTronics Stone Solutions, LLC | 1 | $125 |
| Pfizer Inc. PFE | 4 | $97.73 |
| Progenics Pharmaceuticals, Inc. | 3 | $61.57 |
| Boston Scientific Corporation BSX | 2 | $28.82 |
| Abbvie Inc. ABBV | 2 | $28.05 |
| 180 Medical, Inc. | 1 | $27.66 |
| Tolmar, Inc. | 1 | $24.39 |
| Calyxo, Inc. | 1 | $21.85 |
| Urogen Pharma, Inc. URGN | 1 | $21.37 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.